Geographic Distribution of HCV-GT3 Subtypes and Naturally Occurring Resistance Associated Substitutions

<b>Background:</b> Little is known about the frequency or geographic distributions of naturally occurring resistance-associated substitutions (RASs) in the nonstructural protein 5A (NS5A) domain of hepatitis-C virus (HCV) genotype-3 (GT-3) different subtypes. We investigated naturally oc...

Full description

Bibliographic Details
Main Authors: Sabrina Bagaglio, Emanuela Messina, Hamid Hasson, Andrea Galli, Caterina Uberti-Foppa, Giulia Morsica
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/11/2/148
Description
Summary:<b>Background:</b> Little is known about the frequency or geographic distributions of naturally occurring resistance-associated substitutions (RASs) in the nonstructural protein 5A (NS5A) domain of hepatitis-C virus (HCV) genotype-3 (GT-3) different subtypes. We investigated naturally occurring GT-3 RASs that confer resistance to NS5A inhibitors. <b>Methods:</b> From a publicly accessible database, we retrieved 58 complete GT-3 genomes and an additional 731 worldwide NS5A sequences from patients infected with GT-3 that were naive to direct-acting antiviral treatment. <b>Results:</b> We performed a phylogenetic analysis of NS5A domains in complete HCV genomes to determine more precisely HCV-GT-3 subtypes, based on commonly used target regions (e.g., 5&#8242;untranslated region and NS5B partial domain). Among 789 NS5A sequences, GT-3nonA subtypes were more prevalent in Asia than in other geographic regions (<i>p</i> &lt; 0.0001). The A30K RAS was detected more frequently in HCV GT-3nonA (84.6%) than in GT-3A subtypes (0.8%), and the amino acid change was polymorphic in isolates from Asia. <b>Conclusions:</b> These results provided information on the accuracy of HCV-3 subtyping with a phylogenetic analysis of the NS5A domain with data from the Los Alamos HCV genome database. This information and the worldwide geographic distribution of RASs according to HCV GT-3 subtypes are crucial steps in meeting the challenges of treating HCV GT-3.
ISSN:1999-4915